Longer procoagulant phospholipid-dependent clotting time, lower endogenous thrombin potential and higher tissue factor pathway inhibitor concentrations are associated with increased VTE occurrence in patients with newly diagnosed multiple myeloma: results of the prospective ROADMAP-MM-CAT study

Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer‐Associated Thrombosis: The Observational ROADMAP‐CAT Study

(2018) Konstantinos Syrigos et al.   ONCOLOGIST

A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS–Cancer‐Associated Thrombosis Study

(2017) Grigoris T. Gerotziafas et al.   ONCOLOGIST

Eculizumab decreases the procoagulant activity of extracellular vesicles in paroxysmal nocturnal hemoglobinuria: A pilot prospective longitudinal clinical study

(2017) Adeline Wannez et al.   THROMBOSIS RESEARCH

PO-63 - Exhausted platelets in cancer patients with high risk of venous thromboembolism and poor prognosis

(2016) J. Riedl et al.   THROMBOSIS RESEARCH

Effect of serum monoclonal protein concentration on haemostasis in patients with multiple myeloma

(2015) Heyu Huang et al.   BLOOD COAGULATION & FIBRINOLYSIS

Large registry analysis to accurately define second malignancy rates and risks in a well-characterized cohort of 744 consecutive multiple myeloma patients followed-up for 25 years

(2015) M. Engelhardt et al.   HAEMATOLOGICA

Establishing a reference range for thrombin generation using a standard plasma significantly improves assay precision

(2015) C.N. Bagot et al.   THROMBOSIS RESEARCH

Large external quality assessment survey on thrombin generation with CAT: further evidence for the usefulness of normalisation with an external reference plasma

(2015) Julien Perrin et al.   THROMBOSIS RESEARCH

Large registry analysis to accurately define second malignancy rates and risks in a well-characterized cohort of 744 consecutive multiple myeloma patients followed-up for 25 years

(2015) M. Engelhardt et al.   HAEMATOLOGICA

Venous Thromboembolism in Patients With Myeloma

(2014) Maeve P. Crowley et al.   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS

International Myeloma Working Group Consensus Statement for the Management, Treatment, and Supportive Care of Patients With Myeloma Not Eligible for Standard Autologous Stem-Cell Transplantation

(2014) Antonio Palumbo et al.   JOURNAL OF CLINICAL ONCOLOGY

Differing coagulation profiles of patients with monoclonal gammopathy of undetermined significance and multiple myeloma

(2014) Maeve P. Crowely et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma

(2014) S Vincent Rajkumar et al.   LANCET ONCOLOGY

Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myeloma

(2014) M A Dimopoulos et al.   LEUKEMIA

Venous Thromboembolism in Multiple Myeloma

(2014) Tommaso Za et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Lobectomy and postoperative thromboprophylaxis with enoxaparin improve blood hypercoagulability in patients with localized primary lung adenocarcinoma

(2013) Chrysoula Papageorgiou et al.   THROMBOSIS RESEARCH

High D-dimer levels are associated with poor prognosis in cancer patients

(2012) C. Ay et al.   HAEMATOLOGICA

Thrombosis in multiple myeloma (MM)

(2012) Cesarman-Maus   Hematology

Evaluation of a standardized protocol for thrombin generation measurement using the calibrated automated thrombogram: An international multicentre study

(2012) Yesim Dargaud et al.   THROMBOSIS RESEARCH

Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide

(2011) A. Larocca et al.   BLOOD

Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized Trial

(2011) Antonio Palumbo et al.   JOURNAL OF CLINICAL ONCOLOGY

Prediction of Venous Thromboembolism in Patients With Cancer by Measuring Thrombin Generation: Results From the Vienna Cancer and Thrombosis Study

(2011) Cihan Ay et al.   JOURNAL OF CLINICAL ONCOLOGY

Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement

(2011) M A Dimopoulos et al.   LEUKEMIA

Multiple Myeloma, Venous Thromboembolism, and Treatment-Related Risk of Thrombosis

(2011) Elena Zamagni et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Thrombosis in Multiple Myeloma

(2011) S. Y. Kristinsson   Hematology-American Society of Hematology Education Program

Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma

(2010) J. J. A. Auwerda et al.   THROMBOSIS AND HAEMOSTASIS

Clinical evaluation of a new functional test for detection of plasma procoagulant phospholipids

(2009) Patrick van Dreden et al.   BLOOD COAGULATION & FIBRINOLYSIS

Plasma thrombomodulin activity, tissue factor activity and high levels of circulating procoagulant phospholipid as prognostic factors for acute myocardial infarction

(2009) Patrick Van Dreden et al.   BLOOD COAGULATION & FIBRINOLYSIS

Increased levels of tissue factor activity and procoagulant phospholipids during treatment of children with acute lymphoblastic leukaemia

(2009) Pascale Schneider et al.   BRITISH JOURNAL OF HAEMATOLOGY

Elevated circulating soluble thrombomodulin activity, tissue factor activity and circulating procoagulant phospholipids: New and useful markers for pre-eclampsia?

(2009) Aurélie Rousseau et al.   European Journal of Obstetrics & Gynecology and Reproductive Biology

Venous Thromboembolism in the Hematologic Malignancies

(2009) Anna Falanga et al.   JOURNAL OF CLINICAL ONCOLOGY

D-Dimer and Prothrombin Fragment 1 + 2 Predict Venous Thromboembolism in Patients With Cancer: Results From the Vienna Cancer and Thrombosis Study

(2009) Cihan Ay et al.   JOURNAL OF CLINICAL ONCOLOGY

High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)

(2008) C. Ay et al.   BLOOD

Development and validation of a predictive model for chemotherapy-associated thrombosis

(2008) A. A. Khorana et al.   BLOOD

Assessment of thrombin generation II: Validation of the Calibrated Automated Thrombogram in platelet-poor plasma in a clinical laboratory

(2008) Arne W. J. H. Dielis et al.   THROMBOSIS AND HAEMOSTASIS